logo

Assessment of the Impact of the COVID-19 Pandemic on People with Rheumatic Diseases in Europe

SCIENTIFIC publications

The public health emergency provoked by the COVID-19 pandemic is paralleled by an economic and social crisis to which, according to research, patients with rheumatic and musculoskeletal diseases are particularly vulnerable.

Country: Europe Date: June 2-5th 2021

Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Results from the first phase of the REUMAVID study.

Country Comparison on the Impact of the COVID-19 Pandemic on Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)

Gender differences on the Impact of the COVID-19 Pandemic and Lockdown in Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)

Impact of the COVID-19 Pandemic and Lockdown on Wellbeing on Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)

Fears and Hopes during the COVID-19 Pandemic in Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)

Country: UK

Date: April 26-28th 2021

Evaluation of the impact of the COVID-19 pandemic on patients with rheumatic diseases in the UK: results from the REUMAVID study

Country: France

Evaluation of the impact of the COVID-19 pandemic on patients with rheumatic diseases in the UK: results from the REUMAVID study

Click here

Conference: ACR 2020 Country: USA  Date: May, 19-22th 2020

Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Preliminary Results from the REUMAVID Study

Click here

 

Country: Spain

Date: December 13-16th 2020


Evaluación del impacto de la pandemia COVID-19 en pacientes con enfermedades reumáticas y musculoesqueléticas en España. Resultados del estudio REUMAVID

Click Here

 

REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)

Supported by

© 2021 All Rights Reserved

Centro de preferencias de privacidad

      Necessary

      Advertising

      Analytics

      Other

      This website uses its own and third-party cookies to analyze and improve your browsing experience. By continuing to browse, we understand that you accept their use.    More information
      Privacidad